[Highlight] Why Dog Longevity Drugs Are the Fastest Path to Human Longevity with Celine Halioua

This is a short excerpt from our full conversation with Celine Halioua, Founder & CEO of Loyal, which recently raised a $100M Series C, and Village Global GP Sam Kirschner. Celine discusses Loyal's 10-year vision for expanding into cats and humans, why the pharmaceutical industry has been slow to treat aging as a drug category, and why the biological and economic case for going dogs-first is stronger than most people realize. Listen to the full episode here: Thanks for listening — if you like what you hear, please review us on your favorite podcast platform. Check us out on the web at or get in touch with us on X @villageglobal. Want to get updates from us?

You can listen to [Highlight] Why Dog Longevity Drugs Are the Fastest Path to Human Longevity with Celine Halioua online on Radio and Podcast. Open the player on this page to stream the available audio.

[Highlight] Why Dog Longevity Drugs Are the Fastest Path to Human Longevity with Celine Halioua is an episode from Venture Stories by Village Global.

This episode is 00:12:02 long.

This episode was published on Feb 19, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Venture Stories when more episodes are available from the podcast feed.